Live feed
Filing
SC 13D/A
SC 13D/A0001193125-20-072903·Eloxx Pharmaceuticals, Inc.
Schedule 13D ownership disclosure
Eloxx Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 29014R103
Event date: 2020-03-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-20-072903
- Form type
- SC 13D/A
- Filer
- Eloxx Pharmaceuticals, Inc.
- CIK
- CIK 1035354
- Filed
- Mar 13, 2020
- Reporting period
- Mar 06, 2020
- Description
- Schedule 13D beneficial ownership